Compare FMC Corp (FMC) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Xylem, Inc. — how do they compare? FMC Corp trades at $11.36 (market cap $1.36B), while Xylem, Inc. trades at $124.38 (market cap $28.86B). The key difference: Xylem, Inc. is far larger — about 21.2× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | XYL | |
|---|---|---|
Market Cap | $1.36B | $28.86B |
Sector | Basic Materials | Industrials |
52-Week High | $43.90 | $152.95 |
52-Week Low | $10.72 | $106.34 |
Enterprise Value | $5.50B | $30.12B |
Dividend Yield | 2.95% | 1.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Xylem (XYL) trades at $125.26, up 3.05% over 24 hours, with a bullish technical signal and consistent earnings beats. Revenue grew from $5.5B in 2022 to $9.0B in 2025, with net margins expanding to 10.59%. Recent news highlights partnerships, leadership appointments, and a dividend declaration, reinforcing its position in water technology solutions.
Outlook remains positive with a consensus price target of $152, implying 21% upside. Risks include execution challenges and macroeconomic pressures, but strong cash flow and analyst support suggest long-term growth potential for investors focused on sustainable infrastructure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
